LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 43.65 | 21.74 | 119 | 3754 | 0.0317 | 0.2570 | MN20160310_N01 | F14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 43.65 | 21.74 | 1712 | 3754 | 0.4560 | 0.7995 | MN20160310_N01 | F14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 43.65 | 21.74 | 1476 | 3754 | 0.3932 | 0.7639 | MN20160310_N01 | N05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 43.65 | 21.74 | 1516 | 3754 | 0.4038 | 0.7703 | MN20160310_N01 | N05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 45.62 | 21.74 | 538 | 4150 | 0.1296 | 0.5273 | MN20160310_N01 | D18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 45.62 | 21.74 | 1412 | 4150 | 0.3402 | 0.7347 | MN20160310_N01 | D18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 45.62 | 21.74 | 208 | 4150 | 0.0501 | 0.3473 | MN20160310_N01 | F14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 45.62 | 21.74 | 1856 | 4150 | 0.4471 | 0.7984 | MN20160310_N01 | F14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 45.62 | 21.74 | 1531 | 4150 | 0.3688 | 0.7533 | MN20160310_N01 | N05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 45.62 | 21.74 | 1549 | 4150 | 0.3732 | 0.7560 | MN20160310_N01 | N05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 47.59 | 21.74 | 675 | 4492 | 0.1503 | 0.5632 | MN20160310_N01 | D18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 47.59 | 21.74 | 1528 | 4492 | 0.3402 | 0.7384 | MN20160310_N01 | D18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 47.59 | 21.74 | 301 | 4492 | 0.0670 | 0.4073 | MN20160310_N01 | F14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 47.59 | 21.74 | 2027 | 4492 | 0.4512 | 0.8034 | MN20160310_N01 | F14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 47.59 | 21.74 | 1688 | 4492 | 0.3758 | 0.7610 | MN20160310_N01 | N05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 47.59 | 21.74 | 1732 | 4492 | 0.3856 | 0.7669 | MN20160310_N01 | N05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 49.56 | 21.74 | 867 | 4838 | 0.1792 | 0.6043 | MN20160310_N01 | D18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 49.56 | 21.74 | 1681 | 4838 | 0.3474 | 0.7464 | MN20160310_N01 | D18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 49.56 | 21.74 | 374 | 4838 | 0.0773 | 0.4403 | MN20160310_N01 | F14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 49.56 | 21.74 | 2215 | 4838 | 0.4578 | 0.8093 | MN20160310_N01 | F14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 49.56 | 21.74 | 1811 | 4838 | 0.3743 | 0.7632 | MN20160310_N01 | N05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 49.56 | 21.74 | 1837 | 4838 | 0.3796 | 0.7664 | MN20160310_N01 | N05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 51.53 | 21.74 | 1053 | 5150 | 0.2044 | 0.6354 | MN20160310_N01 | D18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 51.53 | 21.74 | 1835 | 5150 | 0.3563 | 0.7547 | MN20160310_N01 | D18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 51.53 | 21.74 | 504 | 5150 | 0.0978 | 0.4896 | MN20160310_N01 | F14 |